# Paragon 28

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/paragon-28

- Industry: Medical Devices & Equipment
- Headquarters: Englewood, US
- Website: www.paragon28.com
- Latest round: Series B (Aug 14, 2020)
- Investors on record: 2

## About

Based in Colorado, US, and founded in 2010 by Albert DaCosta (CEO), Lee Rosenthal, and Frank Bono (CTO), Paragon 28, Inc. operates as a provider of medical care products that help patients with foot and ankle injuries. In August 2020, Paragon 28, Inc. raised an undisclosed amount of Series B funding co-led by MVM Partners and Piper Sandler Companies. The firm went public in October 2021 under the ticker symbol "FNA" on the New York Stock Exchange. As of 2021, the company has 175 product patents filed and about 1,000 surgeons using Paragon products on a monthly basis.

Paragon 28, Inc. develops tailored solutions and tools to treat foot and ankle conditions. The company provides products by system, which include plating systems, nails, screw systems, hammertoe implants, charcoal systems, staple systems, porous titanium wedges, syndesmosis, total ankle replacement, total talus replacement, and biologics. It also offers products by procedure that include Hallus Valgus, flat root, arthrodesis/deformity correction, fractures, hammertoe, and biologic solutions. Paragon 28 has a comprehensive portfolio that provides its customers with ankle solutions for trauma, arthritis, and limb salvage.

The company generated a revenue of approximately USD 110.98 million in 2020 and USD 106.28 million in 2019.

## Funding rounds

- Series B, Aug 14, 2020 — MVM Partners, Piper Sandler Companies

## Investors

- MVM Partners (https://capitalatlas.ai/funds/mvm-partners) — Series B
- Piper Sandler Companies — Series B